Inventor · disambiguated record
Andrew W. Boyd
Also filed as: BOYD ANDREW · BOYD ANDREW W · BOYD ANDREW WALLACE
9 granted patents·2 pending applications·85 citations·filing 1992–2016
87Inventor score
Files withAMRAD CORP LTD4INST MEDICAL W & E HALL3UNIV QUEENSLAND2BOYD ANDREW WALLACE1LACKMANN MARTIN1
Top patents by PatentIndex Score
11 records- 0184US7897570B2Method of treatmentINST MEDICAL W & E HALL·Filed 2008·Granted Mar 1, 2011·6 cites·4 claims
- 0284US7341997B2Method of treatmentINST MEDICAL W & E HALL·Filed 2005·Granted Mar 11, 2008·7 cites·4 claims
- 0369US6020306AReceptor-type tyrosine kinase and use thereofAMRAD CORP LTD·Filed 1996·Granted Feb 1, 2000·28 cites·15 claims
- 0468US5747032AMonoclonal antibody to human granulocyte macrophage colony stimulating factorAMRAD CORP LTD·Filed 1993·Granted May 5, 1998·31 cites·14 claims
- 0548US5674691AMethod of screening for ligands to a receptor-type tyrosine kinaseAMRAD CORP LTD·Filed 1992·Granted Oct 7, 1997·6 cites·6 claims
- 0645US2006140957A1Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasisLACKMANN MARTIN·Filed 2004·Application pending·0 cites
- 0741US10617738B2Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereofUNIV QUEENSLAND·Filed 2016·Granted Apr 14, 2020·0 cites·27 claims
- 0838US2008254023A1Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph ReceptorUNIV QUEENSLAND·Filed 2005·Application pending·0 cites
- 0934US6599709B1Method for screening for soluble ligands to a receptor-type tyrosine kinaseINST MEDICAL W & E HALL·Filed 1999·Granted Jul 29, 2003·1 cites·5 claims
- 1030US5322787ACytokine and bioassay thereforAMRAD CORP LTD·Filed 1992·Granted Jun 21, 1994·6 cites·1 claims
- 1116US7037662B1Receptor-ligand system and assayBOYD ANDREW WALLACE·Filed 1998·Granted May 2, 2006·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Andrew W. Boyd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →